Steven Gutman, Robert Corn | GenomeWeb

Steven Gutman, Robert Corn

Steven Gutman, director of the Office of In Vitro Diagnostic Device Safety and Evaluation, will leave the US Food and Drug Administration by the end of the year for a post in academia, ProteoMonitor’s sister publication Pharmacogenomics Reporter reported this week.
“I made the very difficult decision that it was time for a change,” Gutman told PGx Reporter.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.